adMare Bioinnovations and PRiME Next-Generation Precision Medicine Collaborate to Translate Academic Research into Life Changing Therapeutics
TORONTO, ON — adMare BioInnovations (adMare) and PRiME Next-Generation Precision Medicine (PRiME), an Institutional Strategic Initiative at the University of Toronto, are pleased to announce their new partnership to support… Read More




